Supporting agencies: This article has been supported by UCB Pharma S.A. The sponsor has participated in the development of the investigation project and supported the investigation program, as well as in the decision to submit the article for publication.
For citations:
Karlov V.A., Vlasov P.N., Kozhokaru A.B., Samoilov A.S., Orlova A.S. The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(3):56-62. https://doi.org/10.14412/2074-2711-2020-3-56-62
Views: 458
Email this article 